The victory extends India’s dominance on New Zealand soil in the shortest format and keeps the series alive only in name.
Approval under the EU Clinical Trials Regulation builds on CAMP4’s recent clearances in the United Kingdom, Australia, and Argentina to initiate the Company’s global Phase 1/2 trial of CMP-002 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results